Your browser doesn't support javascript.
loading
Suboptimal adherence to food restrictions requirements related to drug regimens for chronic diseases.
Boggs, Robert L; Engel, Samuel; Wang, Tongtong; Weiss, Tracey Jean; Martin, Ashley A; Yue, Austin; Way, Nate; Ricker, Bryan; Rajpathak, Swapnil N; Lautsch, Dominik.
Afiliação
  • Boggs RL; Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.
  • Engel S; Clinical Development, Merck & Co., Inc, Rahway, NJ, USA.
  • Wang T; Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.
  • Weiss TJ; Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.
  • Martin AA; Cerner Enviza, Kansas, MO, USA.
  • Yue A; Cerner Enviza, Kansas, MO, USA.
  • Way N; Cerner Enviza, Kansas, MO, USA.
  • Ricker B; Cerner Enviza, Kansas, MO, USA.
  • Rajpathak SN; Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.
  • Lautsch D; Center for Observational and Real-World Evidence, Merck & Co., Inc, Rahway, NJ, USA.
Curr Med Res Opin ; 39(4): 517-522, 2023 04.
Article em En | MEDLINE | ID: mdl-36912018
BACKGROUND: Oral medications for chronic conditions often involve a variety of instructions, including time of day/dosing, drug interactions, and food intake restrictions. However, the extent to which patients follow these instructions is unclear. METHODS: We surveyed patients from the US and Europe (UK, France, Germany, Italy, Spain) who were prescribed sulfonylureas (SU: glimepiride, glipizide, or gliclazide) for diabetes or levothyroxine for hypothyroidism. Patients kept a daily diary for 3-5 days documenting their adherence to three criteria: dosing regimen including time of day, warning labels including drug interactions, and food restrictions. RESULTS: A total of 421 US and 493 European patients took the study medications; 546 patients took SU and 368 took levothyroxine. Overall, 48% of patients were males; 46% were age 65 years or older. Despite most patients having received instructions on medication requirements (US 71%, EU 75%), most patients reported being only somewhat knowledgeable (US 69%; EU 71%). Adherence, measured by the proportion of the days a participant was adherent to each category out of the observational period (ranging from 3-5 days), varied by type of instruction, with the poorest adherence observed for food restriction requirements (US 34% of the observation days, EU 26%) compared to warning labels (US 77%, EU 67%) and dosing regimen (US 85%, EU 87%). CONCLUSIONS: Patients adhered to dosing and cautionary instructions across the majority of the study period but were largely non-adherent to food intake restrictions. Improved communication and increased emphasis on food intake restrictions is needed when advising patients on their medications.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Hipotireoidismo Limite: Aged / Female / Humans / Male Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adesão à Medicação / Hipotireoidismo Limite: Aged / Female / Humans / Male Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos